Research and Markets
Analysis of AERS Data on Anti-Diabetics Provides a Detailed Analysis on the Adverse Events Reported in the FDA AERS Database
Published in Obesity and Diabetes Week, April 6th, 2009
This report provides a detailed analysis on the adverse events reported in the FDA AERS database, for the prescribed Thiazolidone derivatives namely Avandia, Actos, Avandamet and Avandaryl, along with Incretins which include Januvia and Byetta, all approved for the treatment of Type II Diabetes Mellitus. It provides a statistical analysis of these leading anti-diabetic therapeutics, from real-time data that includes cases, adverse events, reactions and outcomes, associated with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- American Associates, Ben-Gurion University of the Negev
Ben-Gurion U researchers -- bariatric surgery minimizes pregnancy complications for obese women - Columbia University's Mailman School of Public Health
Differences in neighborhood food environment may contribute to disparities in obesity - Elsevier
Fructose metabolism by the brain increases food intake and obesity - Northwestern University
Compound is key coordinator of clock and metabolism - University of California - Berkeley
Mice stay lean with high-carb diet - University of California - Los Angeles
Bad news for insomniacs: 'hunger hormones' affected by poor sleep - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
